FDA, WebMD expand partnership
This article was originally published in The Tan Sheet
Executive Summary
FDA and WebMD Health Corp. expand their partnership to provide consumers with increased access to FDA's consumer information, the agency says Oct. 29. The second phase of the partnership launched in December 2008 includes additional multimedia tools and content on WebMD's Web site about allergies and asthma, children's health, diabetes, heart health and vitamins and supplements, FDA says. A release says the partnership increased FDA's consumer reach when the agency warned the public to stop using Iovate Pharmaceuticals' weight-loss product Hydroxycut because of serious adverse event reports (1"Health News Daily" May 4, 2009)
You may also be interested in...
FDA, Everyday Health join forces
The agency's collaboration with consumer health information network Everyday Health will allow FDA's food and medical product safety alerts and postings about wellness and prevention to reach Everyday Health's 30 million unique monthly visitors. The Web site's owner, Waterfront Media, and FDA launched the co-branded portal 1www.EverydayHealth.com/FDA, and will jointly publish a weekly newsletter on drug safety, children's health products and cosmetics, according to a Nov. 17 release. FDA also works with WebMD to communicate with consumers (2"The Tan Sheet" Nov. 2, 2009, In Brief)
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.